William D. Waddill, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 3,200 shares at $30.00 ($96K) on 2023-01-09, disclosed to the SEC on 2023-01-11.
Seasonal sale ($96k) by Director — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |